The course of negative symptom in first episode psychosis and the relationship with social recovery

Schizophrenia Research

Volumn 174, Issue 1-3, 2016, Pages 165-171

  Gee, Brioney ^a   Hodgekins, Jo ^a   Fowler, David ^b   Marshall, Max ^c   Everard, Linda ^d   Lester, Helen ^e   Jones, Peter B ^f   Amos, Tim ^g   Singh, Swaran P ^h   Sharma, Vimal ^i,j   Freemantle, Nick ^k   Birchwood, Max ^h  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h UNIVERSITY OF WARWICK   (United Kingdom)

ⁱ UNIVERSITY OF CHESTER   (United Kingdom)

^j CHESHIRE AND WIRRAL PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Early intervention; Functioning; Longitudinal; Negative symptoms; Recovery

Indexed keywords

ADOLESCENCE; ADULT; ARTICLE; CHILDHOOD; DEPRESSION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR RETARDATION; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; SOCIAL ADAPTATION; SYMPTOMATOLOGY; YOUNG ADULT; ADOLESCENT; ANALYSIS OF VARIANCE; COST BENEFIT ANALYSIS; DISEASE EXACERBATION; FAMILY; FOLLOW UP; GENETIC PREDISPOSITION; LONGITUDINAL STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REGRESSION ANALYSIS; SEX DIFFERENCE; SOCIAL BEHAVIOR; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ANALYSIS OF VARIANCE; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SEX FACTORS; SOCIAL BEHAVIOR; TREATMENT OUTCOME; UNITED KINGDOM; YOUNG ADULT;

EID: 84964637808     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.04.017     Document Type: Article

References (39)

1. Addington D., Addington J., Matickatyndale E., Maticka-Tyndale E. Specificity of the Calgary depression scale for schizophrenics. Schizophr. Res. 1994, 11:239-244.
2. Andruff H., Carraro N., Thompson A., Gaudreau P. Latent class growth modelling: a tutorial. Tutor. Quant. Methods Psychol. 2009, 5:11-24.
3. Asparouhov T., Muthén B. Exploratory structural equation modeling. Struct. Equ. Model. 2009.
4. Birchwood M., Lester H., McCarthy L., Jones P., Fowler D., Amos T., Freemantle N., Sharma V., Lavis A., Singh S., Marshall M. The UK national evaluation of the development and impact of early intervention services (the national EDEN studies): study rationale, design and baseline characteristics. Early Interv. Psychiatry 2014, 8:59-67.
5. Blanchard J.J., Kring A.M., Horan W.P., Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr. Bull. 2011, 37:291-299.
6. Boonstra N., Klaassen R., Sytema S., Marshall M., De Haan L., Wunderink L., Wiersma D. Duration of untreated psychosis and negative symptoms-a systematic review and meta-analysis of individual patient data. Schizophr. Res. 2012, 142:12-19.
7. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
8. Chen L., Johnston J.A., Kinon B.J., Stauffer V., Succop P., Marques T.R., Ascher-Svanum H. The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial. BMC Psychiatry 2013, 13:320.
9. Department of Health The Mental Health Policy Implementation Guide 2001, Department of Health, London.
10. Edwards J., Mcgorry P.D., Waddell F.M., Harrigan S.M. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr. Res. 1999, 40:147-158.
11. Evensen J., Røssberg J.I., Barder H., Haahr U., Hegelstad W.T.V., Joa I., Johannessen J.O., Larsen T.K., Melle I., Opjordsmoen S., Rund B.R., Simonsen E., Vaglum P., McGlashan T., Friis S. Flat affect and social functioning: a 10 year follow-up study of first episode psychosis patients. Schizophr. Res. 2012, 139:99-104.
12. Fowler D., Hodgekins J., Painter M., Reilly T., Crane C., Macmillan I., Mugford M., Croudace T., Jones P.B. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC trial platform study (improving social recovery in early psychosis). Psychol. Med. 2009, 39:1627-1636.
13. Fowler D., Hodgekins J., Arena K., Turner R., Lower R., Wheeler K., Corlett E., Reilly T., Wilson J. Early detection and psychosocial intervention for young people who are at risk of developing long term socially disabling severe mental illness: should we give equal priority to functional recovery and complex emotional dysfunction as to psychotic symptom. Clin. Neuropsychiatry 2010, 7:63-71.
14. Galderisi S., Mucci A., Bitter I., Libiger J., Bucci P., Fleischhacker W.W., Kahn R.S. Persistent negative symptoms in first episode patients with schizophrenia: results from the European first episode schizophrenia trial. Eur. Neuropsychopharmacol. 2013, 23:196-204.
15. Hodgekins J., French P., Birchwood M., Mugford M., Christopher R., Marshall M., Everard L., Lester H., Jones P., Amos T., Singh S., Sharma V., Morrison A.P., Fowler D. Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group. Schizophr. Res. 2015, 161:188-193.
16. Hodgekins J., Birchwood M., Christopher R., Marshall M., Coker S., Everard L., Lester H., Jones P., Amos T., Singh S., Sharma V., Freemantle N., Fowler D. Investigating trajectories of social recovery in individuals with first episode psychosis: a latent class growth analysis. Br. J. Psychiatry 2015, 207:536-543.
17. Husted J.A., Beiser M., Iacono G.W. Negative symptoms and the early course of schizophrenia. Psychiatry Res. 1992, 43:215-222.
18. IBM Corp IBM SPSS Statistics for Windows, Version 22.0 2013, IBM Corp., Armonk, NY, (Released).
19. Jung T., Wickrama K.A.S. An introduction to latent class growth analysis and growth mixture modeling. Soc. Personal. Psychol. Compass 2008, 2:302-317.
20. Kane J.M., Leucht S., Carpenter D., Docherty J.P. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J. Clin. Psychiatry 2003, 64:5-19.
21. Kavanagh D.J., Saunders J.B., Young R., White A., Jenner L., Clair A., Wallis J. Evaluation of screening and brief intervention for substance abuse in early psychosis. A Report to AUSEINET 1999 1999, University of Queensland, Brisbane.
22. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
23. Kay S.R., Opler L.A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS) 2000, Multi-Health Systems, Toronto.
24. Kelley M.E., Haas G.L., van Kammen D.P. Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem. Schizophr. Res. 2008, 105:188-196.
25. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
26. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation 2013, 170(2):165-172.
27. Larsen T.K., McGlashan T.H., Moe L.C. First-episode schizophrenia: I. Early course parameters. Schizophr. Bull. 1996, 22:241-256.
28. Leamy M., Bird V., Le Boutillier C., Williams J., Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br. J. Psychiatry 2011, 199:445-452.
29. Liemburg E., Castelein S., Stewart R., van der Gaag M., Aleman A., Knegtering H. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J. Psychiatr. Res. 2013, 47:718-725.
30. Mäkinen J., Miettunen J., Isohanni M., Koponen H. Negative symptoms in schizophrenia: a review. Nord. J. Psychiatry 2008, 62:334-341.
31. Muthén L.K., Muthén B.O. Mplus User's Guide 1998-2012, Muthén & Muthén, Los Angeles, CA. seventh ed.
32. Nagin D.S. Group-Based Modelling of Development 2005, Harvard University Press, Cambridge, MA.
33. Pitt L., Kilbride M., Nothard S., Welford M., Morrison A.P. Researching recovery from psychosis: a user-led project. Psychiatr. Bull. 2007, 31:55-60.
34. Savill M., Banks C., Khanom H., Priebe S. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol. Med. 2015, 45:1613-1627.
35. Short S. The United Kingdom 2000 Time Use Survey 2003, Office for National Statistics, Newport, UK.
36. Van den Oord E.J.C.G., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszár J., Murrelle L., Möller H.-J., Middleton L., Muglia P. Factor structure and external validity of the PANSS revisited. Schizophr. Res. 2006, 82:213-223.
37. Van der Gaag M., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr. Res. 2006, 85:280-287.
38. Ventura J., Nuechterlein K.H., Green M.F., Horan W.P., Subotnik K.L., Mintz J. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophr. Res. 2004, 69:333-342.
39. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997, 30:263-274.